Literature DB >> 3740189

Respiratory difficulties with betaxolol.

L S Harris, S H Greenstein, A F Bloom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3740189     DOI: 10.1016/0002-9394(86)90157-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  16 in total

Review 1.  Evolving paradigms in the medical treatment of glaucoma.

Authors:  John S Cohen; Anup K Khatana; Linda J Greff
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

2.  Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.

Authors:  D J Brazier; S E Smith
Journal:  Br J Ophthalmol       Date:  1988-02       Impact factor: 4.638

Review 3.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

4.  Potentially hazardous co-prescribing of beta-adrenoceptor antagonists and agonists in the community.

Authors:  J M Evans; J L Hayes; B J Lipworth; T M MacDonald
Journal:  Br J Gen Pract       Date:  1996-07       Impact factor: 5.386

Review 5.  Beta blockers and the elderly with glaucoma: are we adding insult to injury?

Authors:  E O'Donoghue
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

6.  Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.

Authors:  K G Bauer; F Brunner-Ferber; L M Distlerath; E A Lippa; B Binkowitz; P Till; G A Kaik
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

Review 7.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

8.  Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.

Authors:  Luciano Quaranta; Raffaele Turano; Teodoro Pizzolante
Journal:  Clin Ophthalmol       Date:  2007-06

Review 9.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

10.  Do selective topical beta antagonists for glaucoma have respiratory side effects?

Authors:  J F Kirwan; J A Nightingale; C Bunce; R Wormald
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.